Biomarkers (Fertility)

Fertility biomarkers are physical signs that change in a predictable pattern across the menstrual cycle. Each sign tracks a hormonal event. The main signs are cervical mucus, body temperature, urine hormone tests, and blood hormone tests. Cervical mucus becomes wetter and more slippery as estrogen rises. Basal body temperature (BBT), the resting morning temperature, rises after ovulation as progesterone increases. Urine tests detect the LH (luteinizing hormone) surge and E1G, an estrogen breakdown product. Blood tests drawn on specific cycle days measure hormone levels. Each sign reflects a different event in the cycle.¹

Ultrasound adds a view of the ovary to the hormone data. Serial scans follow a follicle, the small fluid-filled sac that holds the egg, as it grows. Collapse or disappearance of the lead follicle is strong evidence that the egg was released. Studies of the fertile window use this change to mark the day of ovulation. Combined with mucus and hormone signs, scans identify ovulation far more precisely than cycle length alone. Ultrasound still infers ovulation from the behavior of the follicle. No scan directly shows the egg leaving the follicle.²

In fertility charting and RRM-informed workups, biomarkers serve as clinical data. Charted mucus patterns show the fertile window. A sustained temperature rise signals that the cycle has moved past ovulation. Hormone draws timed to the cycle capture each value when it is most informative. Without charting, a clinician must guess where a woman is in her cycle. With charting, the clinician can read how her cycle actually behaves.³

Secondary biomarkers include premenstrual symptoms (see molimina), the consistency of cycle length, bleeding patterns, and what a woman observes and feels at the vulva. These signs reveal patterns across many cycles rather than a single event. Fertility charting combines the main and secondary signs into one record over time.¹